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Introduction
The increased burden of diseases in 
low‑ and middle‑income countries (LMICs) 
cannot be overlooked and noncommunicable 
diseases are responsible for over 50% of 
the total worldwide burden of diseases in 
LMIC.[1,2]
A joint venture (JV) is a transaction in 
which two or more firms agree to contribute 
equity capital to fund as a new company 
which are created for specific purposes in 
developed and developing countries.[3‑5] 
The advantages of joint ventures include: 
helping cost savings,[6] appropriateness 
of assessment of satisfaction and 
performance[7,8] businesses growing faster, 
increasing productivity and generating 
greater profits, both parties sharing the 
risks and costs, accessing new markets, 
and distribution networks. International 
JV is a great opportunity to cooperate 
with people from different countries and 
combine strengths.[9‑12] In healthcare system 
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Abstract
Background: To explore the essence of game changing on applying joint venture (JV) approach 
for healthcare system improvement in developing countries. Methods: This is cross‑sectional study 
exploring the factors influencing the successful implementation of JV for the healthcare services in 
low‑ and middle‑income countries (LMICs). The study included: Qatar Statistical Authority, CIA fact 
book, Ministry of Health Annual Report, Hamad Medical Corporation Annual Report, Organization 
for Economic Cooperation and Development information, and Qatar’s healthcare system history. 
Results: The research indicated that the LMIC healthcare system would benefit from affiliation with 
leading technology partner for healthcare reform. The findings support the view of LMIC healthcare 
systems’ needs to incorporate joint venture approach in implementing JV concept for process 
improvement and knowledge transfer to contribute in country economic growth, development, and 
stability. Current study explored evidence supporting decision maker and management control of JV 
trends in different ways in comparison with developed countries. JV can also help the organization 
to share the risk and cost of large capital investment. Conclusions: The present study supports 
observations on expending the use of JVs as approach for improvement in LMIC healthcare system. 
The current study confirmed the advantages of JV which include helping businesses grow faster, 
increasing productivity, and generating greater profits, both parties sharing the risks and costs, 
accessing new markets and distribution networks.
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under JV aiming potential for collaboration 
with hospitals and health systems pursuing 
partnerships in a number of ways.[13] In 
fact, JV can achieve increasing their market 
position, expanding to new markets, 
having access to new resources, increasing 
their efficiencies, maximizing economies 
of scale, driving new revenue streams 
and growth;[13,14] although, JV may result 
outcome as successes or failures.[15‑17]
The objective of this survey is to explore 
the essence of game changing on process 
leading to healthcare system improvement 
in developing countries, investigating main 
factors effecting the application of JV 
conception for improvement of healthcare 
services and delivery in LMIC.
Methods
This is a cross‑sectional study 
questionnaire aimed to investigate how 
the development of JVs can be performed 
in the improvement of LMICs healthcare 
systems. The study included: Qatar 
Statistical Authority, CIA fact book, 
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Ministry of Health Annual Report, Hamad Medical 
Corporation Annual Report, Organization for Economic 
Co‑operation and Development information, and Qatar’s 
healthcare system history.
At the same time, broad data were collected from journals, 
white papers, industry websites, and other sources about 
JV experience in both developed and developing countries 
with narrative review of particular experience in healthcare 
industry. We approached 292 participants and 188 (64.3%) 
responded from the LMIC healthcare services, such as source 
of supporter, trader, and expert/consultants. The inclusion 
based on the knowledge of healthcare services, barriers, 
needs, and strategic plan for JV healthcare improvement.
Student‘s t test was used to ascertain the significance of 
differences between two means of a continuous variable 
and confirmed by nonparametric Mann–Whitney test. 
Chi‑square test and Fisher’s exact test (two‑tailed) 
were performed to test for differences in proportions 
of categorical variables between two or more groups. 
Principal component analysis with varimax rotation and 
Kaiser normalization was performed to examine the factor 
structure of the JV. The level P < 0.05 was considered as 
the cut‑off value for significance.
Results
Table 1 gives key factors for JV success and improvement 
of LMIC healthcare system. As can be seen from this 
table, developing new skills (72%) and meeting healthcare 
requirements (72%) were measured as success for JV. 
Meanwhile, satisfaction with the overall JV performance 
indicated as 70% expected, 19% better than expected, and 
1% worst (P < 0.001).
Table 2 presents satisfaction level with the JV agreement 
process. As can be seen from this table most were very 
satisfied, satisfied, and not satisfied (P = 0.189).
Table 3 shows the key factors refl ecting company’s 
commitment related to JV. As can be seen from this Table, 
responces often and very often reflected siginificance 
differnces between parent company commitment on JV 
(P < 0.001).
Meanwhile, the JV performance activities, as compared 
with initial expectations at the time the business venture 
was formed, were as follows: cost control (77%), business 
climate (80%), management capability (81%), technology 
transfer (69%), need for parent involvement (85%), customer 
service (81%), interpartner trust (85%), interpartner 
cooperation (85%), interpartner cooperation (4%), and 
achievement of strategic aims (77) (P < 0.001).
Table 4 presents exploratory factor analysis using varimax 
rotation for the elements of trust concerning Partner 
Company. The analysis based on the 21 items produced 
four factors with Cronbach’s alpha’s for the underlying 
factors were 0.81, 0.85, 0.87, and 89 which the figures 
are greater than 0.70, which is a very good indicator of 
reliability.
Table 1: The key factors for JV success and improvement 
of LMIC healthcare system (n=188)
Important factors for JV 
success
Ranking %
Least/average 
important
Most 
important
Minimize risks 60 40
Lowering costs 48 52
Creating new skills 28 72
Obstructing competition 96 4
Providing healthcare needs 28 72
Creating new technologies 64 36
Trust between partners 17 83
Chi‑square P<0.001
Table 2: The satisfaction level with the JV agreement process (n=188)
Governance aspects Level of satisfaction %
Not satisfied Satisfied Very satisfied
Protection of intellectual property (IP) 36 40 24
The ownership of new IP developed by the JV 35 35 30
Resolution/disagreements among JV partners 24 38 38
Confirmation of work plan performance among JV partners 27 43 30
Chi‑square P=0.189 (not significant)
Table 3: The key factors reflecting company’s commitment related to JV (n=188)
Parent company commitment Frequency
Never Sometimes Often Very often
To ensure expectation from JV 10 13 48 29
To increasing levels of assistance to JV 6 33 39 10
To support with managerial resources on a long term, expatriate basis 10 26 35 29
To increase the scale of operations 10 23 48 19
To view common situation 19 35 39 6
Chi‑square P<0.001
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Discussion
The current study aimed to assess the impact of quality in 
affiliation with experience of foreign international partner 
JV and accordingly reducing the risk of environmental 
uncertainty. The most important determining JV issues 
for partners are: trust, composition of governing bodies, 
strategic compatibility, formal structure, interaction, and 
communication between partners. This is confirmative 
with previously reported studies.[3‑5,8] The new forms of 
coordination, including association and close cooperation 
between companies, influence how tasks should be 
designed and practiced.[16]
The most important factor regarding JV success for the 
improvement of LMIC healthcare approach was 72% 
related to the developing new skills and meeting healthcare 
needs activities. These cover strengths, weakness, gaps, 
and opportunities in healthcare system.[18] Further, the 
trust between partners is essential; in this study, 83% 
was considered as high degree of trust between partners 
which is considered important for mutually constructive 
relationship. This is supported with the previously reported 
study.[11] This approach can normalize the relationships 
between firms, reduces complex agreements, permits 
information exchange, and reduces transaction costs.[17] 
About 73% indicated their satisfaction was expected. This 
is in line with the previous studies which reported that 
more than half of their companies’ JVs met or exceeded 
expectations.[19‑21]
Several studies support the idea that partners are willing 
to establish partnership with foreign firms to enhance 
their competitive position, transfer technology, expand 
to foreign markets, benefit from new sources of finance 
and the government’s financial incentives, and learn 
new management practices.[19‑21] Further, the effects of 
technology transfer on the local companies’ corporate 
and human resource performances are not sufficient 
yet[22,23] (Yin and Bao 2006). Furthermore, in most JVs 
and much more in developing countries culture aspect 
and political environment plays a critical role in the JV 
success.[24‑26] Currently, hospitals and health systems are 
rapidly increasing using joint ventures to meet multiple 
goals, such as providing high‑quality care, expanding 
services, dividing risk and greater profit.
Conclusions
The current study showed that the primary priority 
in LMICs has been moved more toward the need for 
development in the quality and efficiency of health 
services. Factors influencing JV in healthcare services and 
quality can be improved by leadership, strategic planning, 
education and training, effective management, allocated 
availability of human and financial resources, employees 
Table 4: Factorial analysis of the elements of trust related to the partner company (n=188)
Factor 
Loads
Eigen 
value
% Variance 
explained
Cumulative 
percent
Cronbach’s 
Alpha
Key success factors for successful joint venture 3.57 15.28 61.50 0.81
JV formal constitution 0.75
Structure of governing bodies 0.77
JV strategic agreement 0.80
Confidence between partners 0.83
Reciprocal action between staffs 0.63
Communication between JV companies 0.60
Partner capable and committed 10.95 12.20 64.84 0.85
Rely on partner to do their part 0.73
Partner capable and competent 0.79
Partner knowledgeable about JV 0.82
Partner makes sensible JV decisions 0.67
Partner to abide by JV management 0.63
Partner committed to JV success 0.65
Partner deceives 3.40 10.24 69.63 0.87
Partner prepared to deceive −0.68
Partner present facts that look good −0.79
Partner alter facts to get what they want −0.81
Partner promise even if cannot do them −0.73
Partner cares 3.81 9.76 76.42 0.89
Partner honest and truthful in dealings 0.67
Partner make sure company not damaged 0.72
Partner cares and responsibility 0.74
Partner looks out for company’s interests 0.82
Partner is on company’s side 0.88
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and processes, collaboration, and cooperation among 
providers. Overall, the current study confirmed advantages 
of joint venture include helping businesses to grow faster, 
increasing productivity, and generating greater profits, both 
parties sharing the risks and costs, accessing new markets, 
and distribution networks. The results suggest International 
JV contributes to country growth and stability.
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